ATNM · Actinium Pharmaceuticals, Inc. · Executive Compensation

$1.31 +0.00 (+0.00%)

Market Cap

$38.67M

31.44M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$733,200	$440,000	—	—	—	—	$1,173,200
Steve O’Loughlin	Chief Financial Officer	$436,800	$145,000	—	—	—	—	$581,800

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$705,000	$500,000	—	$3,499,999	—	—	$4,704,999
Steve O’Loughlin	Chief Financial Officer	$420,000	$170,000	—	$900,000	—	—	$1,490,000

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$665,000	$480,000	—	$2,875,167	—	—	$4,020,167
Steve O’Loughlin	Chief Financial Officer	$400,000	$185,000	—	$891,144	—	—	$1,476,144

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$615,000	$430,000	—	$1,290,323	—	—	$2,335,323
Steve O’Loughlin	Chief Financial Officer	$370,000	$150,000	—	$447,034	—	—	$967,034
Mark S. Berger	Former Chief Medical Officer	$304,962	—	—	$279,395	—	—	$584,357
Dale L. Ludwig	Former Chief Scientific and Technology Officer	$213,068	—	—	—	—	—	$213,068

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$578,191	$315,000	—	$938,537	—	—	$1,831,728
Mark S. Berger	Former Chief Medical Officer	$415,000	$100,000	—	$314,958	—	—	$829,958
Steve O’Loughlin	Chief Financial Officer	$330,000	$90,000	—	$398,640	—	—	$818,640
Dale L. Ludwig	Former Chief Scientific and Technology Officer	$375,000	$105,000	—	$337,453	—	—	$817,453

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer Mark Berger\	$561,350	$300,000	—	$241,367	—	—	$1,102,717
Mark S. Berger	Chief Medical Officer	$405,000	$85,000	—	$64,364	—	—	$554,364
Dale L. Ludwig	Chief Scientific and Technology Officer	$334,750	$97,500	—	$64,364	—	—	$496,614
Steve O’Loughlin	Chief Financial Officer, former Principal Financial Officer	$293,550	$85,000	—	$64,364	—	—	$442,914

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sandesh Seth	Chairman and Chief Executive Officer	$545,000	$280,000	—	$549,253	—	—	$1,374,253
Mark S. Berger	Chief Medical Officer	$400,000	$75,000	—	$137,313	—	—	$612,313
Steve O’Loughlin	Chief Financial Officer, former Principal Financial Officer	$285,000	$75,000	—	$145,552	—	—	$505,552
Dale L. Ludwig	Chief Scientific and Technology Officer	$323,769	—	—	$100,926	—	—	$424,695

Executive changes

Person	Role	Change	Effective	Filed
Steve O'Loughlin	Chief Financial Officer	Resigned	2026-02-27	2026-02-13
Jeffrey W. Chell	Class II director	Appointed	2024-11-27	2024-11-27
Sandesh Seth	Class II director	Appointed	2024-11-27	2024-11-27
June Almenoff, M.D., Ph.D.	director	Appointed	2024-11-01	2024-11-05

Key facts CIK 1388320 CUSIP 00507W206 13F (30d) 30 filings 30 filers Visit website Investor relations